manufacturing defects – Page 33

Fill volume variability during stability testing – FDA/MHRA inspection outcome

Addressing Variability in Fill Volume During Stability Testing: An Investigation Framework In the pharmaceutical manufacturing environment, stability testing is critical for ensuring the quality and consistency of drug products. However,…

Endotoxin OOS after line intervention – FDA/MHRA inspection outcome

Endotoxin Out-of-Specification Events After Line Interventions: A Practical Investigation Guide In the highly regulated pharmaceutical industry, the detection of endotoxin out-of-specification (OOS) results following a line intervention can raise significant…

Sterility test failure post-sterile filtration – CAPA effectiveness failure

Sterility Test Failure After Filtration: Investigating CAPA Effectiveness In the realm of pharmaceutical manufacturing, a sterility test failure post-sterile filtration represents a critical deviation that can lead to significant consequences…

pH drift detected during PAI readiness – patient safety risk analysis

Analysis of pH Drift Detected During Readiness for PAI: Ensuring Patient Safety pH drift during the Pre-Approval Inspection (PAI) process presents significant risks to product integrity and patient safety, particularly…

Visual inspection rejects during PAI readiness – CAPA effectiveness failure

Addressing the Challenges of Visual Inspection Rejections During PAI Readiness In the pharmaceutical manufacturing sector, effective visual inspection processes are critical to ensuring product quality and compliance, particularly during Pre-Approval…

Fill volume variability after line intervention – CAPA effectiveness failure

Analyzing Fill Volume Variability Following Line Interventions: A CAPA Effectiveness Review In the realm of pharmaceutical manufacturing, deviations in fill volume can lead to significant regulatory issues and product quality…

Media fill failure after line intervention – patient safety risk analysis

Analyzing Media Fill Failures Post Line Intervention: A Guide for Pharmaceutical Professionals In pharmaceutical manufacturing, ensuring the integrity of aseptic processes is crucial. A media fill failure after a line…

Sterility test failure during stability testing – CAPA effectiveness failure

Analysis and Resolution of Sterility Test Failures During Stability Testing Sterility test failures during stability testing can significantly impact product integrity and regulatory compliance. As pharmaceutical professionals, understanding the root…

Tag: manufacturing defects

Fill volume variability during stability testing – FDA/MHRA inspection outcome

Endotoxin OOS after line intervention – FDA/MHRA inspection outcome

Sterility test failure post-sterile filtration – CAPA effectiveness failure

pH drift detected during PAI readiness – patient safety risk analysis

Visual inspection rejects during PAI readiness – CAPA effectiveness failure

Fill volume variability after line intervention – CAPA effectiveness failure

Media fill failure after line intervention – patient safety risk analysis

Sterility test failure during stability testing – CAPA effectiveness failure

Fill volume variability during PAI readiness – CAPA effectiveness failure

Media fill failure during stability testing – patient safety risk analysis

CCIT failure during stability testing – patient safety risk analysis

Particulate matter detected during stability testing – CAPA effectiveness failure